Balyasny Asset Management L.P. Has $175,000 Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
Balyasny Asset Management L.P. lessened its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 16.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 57,592 shares of the company’s stock after selling 11,070 shares during the period. Balyasny Asset Management L.P.’s holdings in Zentalis Pharmaceuticals were worth $175,000 at […]
